Trial Outcomes & Findings for Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries (NCT NCT03470675)

NCT ID: NCT03470675

Last Updated: 2026-04-24

Results Overview

Perineal pain 1 week after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good)and 10 highest pain (poor).

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

67 participants

Primary outcome timeframe

1 week after vaginal delivery

Results posted on

2026-04-24

Participant Flow

Participant milestones

Participant milestones
Measure
Epidural Saline + IV Saline
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Overall Study
STARTED
15
26
26
Overall Study
COMPLETED
8
17
21
Overall Study
NOT COMPLETED
7
9
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Epidural Saline + IV Saline
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Overall Study
Lost to Follow-up
7
9
5

Baseline Characteristics

Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Epidural Saline + IV Saline
n=14 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=26 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=25 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Total
n=65 Participants
Total of all reporting groups
Age, Continuous
34.7 Years
n=2 Participants
31.2 Years
n=1 Participants
33.9 Years
n=3 Participants
33 Years
n=24 Participants
Sex: Female, Male
Female
14 Participants
n=2 Participants
26 Participants
n=1 Participants
25 Participants
n=3 Participants
65 Participants
n=24 Participants
Sex: Female, Male
Male
0 Participants
n=2 Participants
0 Participants
n=1 Participants
0 Participants
n=3 Participants
0 Participants
n=24 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=2 Participants
0 Participants
n=1 Participants
0 Participants
n=3 Participants
0 Participants
n=24 Participants
Race (NIH/OMB)
Asian
0 Participants
n=2 Participants
0 Participants
n=1 Participants
0 Participants
n=3 Participants
0 Participants
n=24 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=2 Participants
0 Participants
n=1 Participants
0 Participants
n=3 Participants
0 Participants
n=24 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=2 Participants
5 Participants
n=1 Participants
5 Participants
n=3 Participants
16 Participants
n=24 Participants
Race (NIH/OMB)
White
8 Participants
n=2 Participants
18 Participants
n=1 Participants
18 Participants
n=3 Participants
44 Participants
n=24 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=2 Participants
0 Participants
n=1 Participants
0 Participants
n=3 Participants
0 Participants
n=24 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=2 Participants
3 Participants
n=1 Participants
2 Participants
n=3 Participants
5 Participants
n=24 Participants
Race/Ethnicity, Customized
Hispanic LatinX
0 Participants
n=2 Participants
1 Participants
n=1 Participants
1 Participants
n=3 Participants
2 Participants
n=24 Participants
Race/Ethnicity, Customized
Not LatinX
14 Participants
n=2 Participants
25 Participants
n=1 Participants
24 Participants
n=3 Participants
63 Participants
n=24 Participants
Region of Enrollment
United States
14 participants
n=2 Participants
26 participants
n=1 Participants
25 participants
n=3 Participants
65 participants
n=24 Participants
Current Smoker
1 Participants
n=2 Participants
0 Participants
n=1 Participants
0 Participants
n=3 Participants
1 Participants
n=24 Participants
Gravida
1 Time
10 number of participants
n=2 Participants
17 number of participants
n=1 Participants
14 number of participants
n=3 Participants
41 number of participants
n=24 Participants
Gravida
2 Times
1 number of participants
n=2 Participants
6 number of participants
n=1 Participants
9 number of participants
n=3 Participants
15 number of participants
n=24 Participants
Gravida
Greater than 2 times
3 number of participants
n=2 Participants
3 number of participants
n=1 Participants
2 number of participants
n=3 Participants
8 number of participants
n=24 Participants
Para
No births
2 number of participants
n=2 Participants
5 number of participants
n=1 Participants
3 number of participants
n=3 Participants
10 number of participants
n=24 Participants
Para
1 birth
11 number of participants
n=2 Participants
17 number of participants
n=1 Participants
16 number of participants
n=3 Participants
44 number of participants
n=24 Participants
Para
2 births
1 number of participants
n=2 Participants
4 number of participants
n=1 Participants
6 number of participants
n=3 Participants
11 number of participants
n=24 Participants
Gestational Age (weeks)
39.1 Weeks
STANDARD_DEVIATION 1.1 • n=2 Participants
39.5 Weeks
STANDARD_DEVIATION .09 • n=1 Participants
39.3 Weeks
STANDARD_DEVIATION 1 • n=3 Participants
39.3 Weeks
STANDARD_DEVIATION 1 • n=24 Participants
Labor Type
Spontaneous
8 Participants
n=2 Participants
16 Participants
n=1 Participants
9 Participants
n=3 Participants
33 Participants
n=24 Participants
Labor Type
Induction
6 Participants
n=2 Participants
10 Participants
n=1 Participants
16 Participants
n=3 Participants
32 Participants
n=24 Participants
Rupture of Membranes
Spontaneous
7 participants
n=2 Participants
14 participants
n=1 Participants
4 participants
n=3 Participants
25 participants
n=24 Participants
Rupture of Membranes
Artificial
7 participants
n=2 Participants
12 participants
n=1 Participants
21 participants
n=3 Participants
40 participants
n=24 Participants
Fetal Presentation
Cephalic Presentation
11 Participants
n=2 Participants
17 Participants
n=1 Participants
18 Participants
n=3 Participants
46 Participants
n=24 Participants
Fetal Presentation
Vertex Presentation
3 Participants
n=2 Participants
9 Participants
n=1 Participants
7 Participants
n=3 Participants
19 Participants
n=24 Participants
Prostaglandin Cervical Ripening
3 Participants
n=2 Participants
5 Participants
n=1 Participants
8 Participants
n=3 Participants
16 Participants
n=24 Participants
Oxytocin Augmentation
Oxytocin augmentation
12 Participants
n=2 Participants
25 Participants
n=1 Participants
24 Participants
n=3 Participants
61 Participants
n=24 Participants
Oxytocin Augmentation
No oxytocin augmentation
2 Participants
n=2 Participants
1 Participants
n=1 Participants
1 Participants
n=3 Participants
4 Participants
n=24 Participants
1st Stage of Labor (minutes)
734 Minutes
n=2 Participants
510 Minutes
n=1 Participants
540 Minutes
n=3 Participants
579 Minutes
n=24 Participants
2nd stage of labor (minutes)
30-60 minutes
5 Participants
n=2 Participants
9 Participants
n=1 Participants
11 Participants
n=3 Participants
25 Participants
n=24 Participants
2nd stage of labor (minutes)
61-120 Minutes
2 Participants
n=2 Participants
8 Participants
n=1 Participants
9 Participants
n=3 Participants
19 Participants
n=24 Participants
2nd stage of labor (minutes)
Greater than 120 Minutes
7 Participants
n=2 Participants
9 Participants
n=1 Participants
5 Participants
n=3 Participants
21 Participants
n=24 Participants
Delivery Mode
Vaginal Unassisted
8 Participants
n=2 Participants
16 Participants
n=1 Participants
11 Participants
n=3 Participants
35 Participants
n=24 Participants
Delivery Mode
Vaginal Operative
6 Participants
n=2 Participants
10 Participants
n=1 Participants
14 Participants
n=3 Participants
30 Participants
n=24 Participants
Operative Type
Forceps
4 Participants
n=2 Participants
9 Participants
n=1 Participants
12 Participants
n=3 Participants
25 Participants
n=24 Participants
Operative Type
Vacuum
2 Participants
n=2 Participants
1 Participants
n=1 Participants
2 Participants
n=3 Participants
5 Participants
n=24 Participants
Degree Perineal Laceration
3rd degree laceration
13 Participants
n=2 Participants
20 Participants
n=1 Participants
22 Participants
n=3 Participants
55 Participants
n=24 Participants
Degree Perineal Laceration
4th degree laceration
1 Participants
n=2 Participants
6 Participants
n=1 Participants
3 Participants
n=3 Participants
10 Participants
n=24 Participants
Suture Repair Style
Uninterrupted
4 Participants
n=2 Participants
9 Participants
n=1 Participants
7 Participants
n=3 Participants
20 Participants
n=24 Participants
Suture Repair Style
Interrupted
2 Participants
n=2 Participants
4 Participants
n=1 Participants
6 Participants
n=3 Participants
12 Participants
n=24 Participants
Suture Repair Style
Interrupted + Uninterrupted
8 Participants
n=2 Participants
13 Participants
n=1 Participants
12 Participants
n=3 Participants
33 Participants
n=24 Participants
Fetal Weight
3450 Grams
STANDARD_DEVIATION 478 • n=2 Participants
3410 Grams
STANDARD_DEVIATION 457 • n=1 Participants
3555 Grams
STANDARD_DEVIATION 417 • n=3 Participants
3470 Grams
STANDARD_DEVIATION 456 • n=24 Participants
Plan to Breastfeed
14 Participants
n=2 Participants
25 Participants
n=1 Participants
24 Participants
n=3 Participants
63 Participants
n=24 Participants
NRS Pain Score at Study Drug Administration
2 Score on Scale
n=2 Participants
0 Score on Scale
n=1 Participants
2 Score on Scale
n=3 Participants
1 Score on Scale
n=24 Participants
ACRI Questionnaire
.5 score on scale
n=2 Participants
1 score on scale
n=1 Participants
5 score on scale
n=3 Participants
2 score on scale
n=24 Participants

PRIMARY outcome

Timeframe: 1 week after vaginal delivery

Population: Epidural saline + IV saline group 1 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 1 lost to follow up

Perineal pain 1 week after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good)and 10 highest pain (poor).

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=24 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=13 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Perineal Pain in Postpartum Patients 1 Week After Obstetric Anal Sphincter Injuries.
2.4 score on a scale
Interval 1.7 to 3.1
3.5 score on a scale
Interval 2.3 to 4.7
2.7 score on a scale
Interval 2.0 to 3.4

SECONDARY outcome

Timeframe: Day 1 after delivery

Population: Epidural Morphine 3 mg + saline group 3 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 1 lost to follow up

Perineal pain day 1 after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=24 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=14 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=23 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Perineal Pain
12.9 score on a scale
Interval 10.0 to 15.8
14.4 score on a scale
Interval 10.0 to 18.9
10.4 score on a scale
Interval 7.9 to 12.9

SECONDARY outcome

Timeframe: 1 week after delivery

Population: Epidural saline + IV saline group 1 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 1 lost to follow up

Perineal pain day 7 after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=24 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=13 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Perineal Pain
8.9 score on a scale
Interval 6.6 to 11.2
9.5 score on a scale
Interval 6.9 to 12.1
9.4 score on a scale
Interval 6.2 to 12.7

SECONDARY outcome

Timeframe: 1 week after delivery

Population: Epidural saline + IV saline group 1 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 1 lost to follow up

Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment (poor) to 95 high maternal infant attachment (good).

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=24 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=13 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Assessment of Maternal-infant Bonding
83.8 Score on a scale
Interval 81.8 to 85.9
82.5 Score on a scale
Interval 78.4 to 86.7
79.1 Score on a scale
Interval 73.9 to 84.2

SECONDARY outcome

Timeframe: 1 week after delivery

Population: Epidural saline + IV saline group 1 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 1 lost to follow up

Presence of postpartum depression 7 days after delivery determined by using the Edinburgh Postnatal Depression Scale questionnaire. The questionnaire uses 10 questions scored 0 low to 3 high for a total score of 0 low- 30 high. High scores indicate potential for depression.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=24 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=13 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Presence of Postpartum Depression
6.7 score on a scale
Interval 4.9 to 9.4
5.7 score on a scale
Interval 2.9 to 8.6
7.0 score on a scale
Interval 4.7 to 9.4

SECONDARY outcome

Timeframe: 1 week after delivery

Population: Epidural saline + IV saline group 1 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 1 lost to follow up

Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=24 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=13 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Brief Pain Inventory (BPI-ST Short Form) Current Pain
2.2 score on a scale
Interval 1.6 to 2.9
3.0 score on a scale
Interval 2.2 to 3.8
2.3 score on a scale
Interval 1.6 to 3.1

SECONDARY outcome

Timeframe: 6 weeks after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

Presence of postpartum depression 6 weeks after delivery determined by using the Edinburgh Postnatal Depression Scale questionnaire. The questionnaire uses 10 questions scored 0 low to 3 high for a total score of 0 low 30 high. High scores indicate potential for depression.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=22 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Presence of Postpartum Depression
4.8 score on a scale
Interval 3.3 to 6.3
5.1 score on a scale
Interval 2.6 to 7.6
4.7 score on a scale
Interval 2.8 to 6.6

SECONDARY outcome

Timeframe: 6 weeks after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

Perineal pain 6 weeks after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=22 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Perineal Pain
3.8 score on a scale
Interval 1.9 to 5.7
1.7 score on a scale
Interval 0.3 to 3.1
5.2 score on a scale
Interval 1.4 to 9.0

SECONDARY outcome

Timeframe: 6 weeks after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment to 95 high maternal infant attachment.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=22 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Assessment of Maternal-infant Bonding
85.0 Score on a scale
Interval 82.4 to 87.7
83.2 Score on a scale
Interval 78.8 to 87.6
80.9 Score on a scale
Interval 76.8 to 85.1

SECONDARY outcome

Timeframe: 6 weeks after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 7 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=22 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=19 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Brief Pain Inventory (BPI-ST Short Form) Current Pain
.7 score on a scale
Interval 0.1 to 1.3
.3 score on a scale
Interval 0.0 to 0.6
.5 score on a scale
Interval 0.1 to 1.0

SECONDARY outcome

Timeframe: 3 months after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 4 lost to follow up

Perineal pain 3 months after delivery using the McGill Pain Questionnaire (MPQ). This is a 15 question survey describing pain on a scale. The scale is scored 0 no pain and 3 severe pain.Combined score 0 low and 45 high pain.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Perineal Pain
1 score on a scale
Interval 0.4 to 1.7
.8 score on a scale
Interval 0.3 to 2.0
3.2 score on a scale
Interval 0.8 to 5.6

SECONDARY outcome

Timeframe: 3 months after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 4 lost to follow up

Assessment of maternal infant bonding using the Maternal Postnatal Attachment Scale (MPAS) questionnaire. 19 total question survey which is scored 1= low attachment and 5 = high attachment for each question. Total scores 19 low attachment to 95 high maternal infant attachment.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Assessment of Maternal-infant Bonding
4.4 Scores on a scale
Interval 3.1 to 5.7
4.0 Scores on a scale
Interval 2.3 to 5.8
3.6 Scores on a scale
Interval 2.0 to 5.3

SECONDARY outcome

Timeframe: 3 months after delivery

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 4 lost to follow up

Female Sexual Function Index questionnaire (FSFI).This is a 19 question survey which is scored 2 low sexual function to 36 high sexual function.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Female Sexual Function
14.8 Score on scale 2 low 36 high
Interval 11.1 to 18.5
13 Score on scale 2 low 36 high
Interval 8.4 to 17.6
14.2 Score on scale 2 low 36 high
Interval 10.2 to 18.2

SECONDARY outcome

Timeframe: 3 months after delivery

Population: Epidural saline + IV saline group 4 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

Part 1 of the 7 question survey (Current Pain). 0 no pain -10 worst pain you can imagine scale.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Brief Pain Inventory (BPI-ST Short Form) Current Pain
0.0 score on a scale
Interval 0.0 to 0.2
.2 score on a scale
Interval 0.2 to 0.7
.6 score on a scale
Interval 0.0 to 1.1

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher physical function.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Physical Function Question Only)
54.8 T score
Interval 52.9 to 56.6
52.9 T score
Interval 48.4 to 57.5
54.8 T score
Interval 52.7 to 56.8

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 anxiety rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher anxiety.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Anxiety Function Question Only)
46.7 T score
Interval 43.9 to 49.6
44.8 T score
Interval 39.3 to 50.3
45.3 T score
Interval 43.0 to 53.6

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher depression.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Depressive Symptoms Question Only)
43.6 T score
Interval 41.2 to 45.9
45 T score
Interval 42.1 to 48.0
43 T score
Interval 40.9 to 45.2

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of fatigue.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Fatigue Question Only)
50.0 T score
Interval 47.9 to 53.2
45.9 T score
Interval 41.6 to 50.3
48.1 T score
Interval 44.1 to 52.1

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of sleep disturbance.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Sleep Disturbance Question Only)
54.8 T score
Interval 51.1 to 58.6
58.3 T score
Interval 55.6 to 61.0
56.0 T score
Interval 54.0 to 57.9

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates higher level of social function.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Social Function Question Only)
55.3 T score
Interval 52.4 to 58.2
55.8 T score
Interval 50.7 to 61.0
53.8 T score
Interval 50.3 to 57.3

SECONDARY outcome

Timeframe: 3 month

Population: Epidural saline + IV saline group 3 lost to follow up Epidural Morphine 3 mg + saline group 6 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 3 lost to follow up

29 question recovery survey, 28 questions scored 1 low to 5 high and one question scored 0-10 for pain. Low combined total score (poor) 28 High combine 150 total score (good).The PROMIS-29 questionnaire is then scored by summing raw item responses (1-5 scale) for seven domains (four questions each) and a 0-10 pain rating, then converting these to T-scores (mean=50, SD=10). A higher T-score indicates a higher level of pain interference.

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=11 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=20 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Promis 29 Profile (Pain Interference Question Only)
43.5 T score
Interval 41.7 to 45.2
44 T score
Interval 40.6 to 47.5
43 T score
Interval 41.4 to 44.4

SECONDARY outcome

Timeframe: 1 year after delivery

Population: Epidural saline + IV saline group 6 lost to follow up Epidural Morphine 3 mg + saline group 9 lost to follow up Epidural Morphine 3 mg + ketamine .3 mg/kg 4 lost to follow up

Perineal pain 1 year after vaginal delivery measured using the VRS (verbal rating scale). The scale is scored 0 no pain (good) and 10 highest pain (poor).

Outcome measures

Outcome measures
Measure
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=21 Participants
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Epidural Saline + IV Saline
n=8 Participants
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=17 Participants
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Perineal Pain
.3 score on a scale
Interval 0.1 to 0.5
.1 score on a scale
Interval 0.1 to 0.2
.5 score on a scale
Interval 0.1 to 1.1

Adverse Events

Epidural Saline + IV Saline

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Epidural Morphine 3 mg + IV Saline

Serious events: 0 serious events
Other events: 14 other events
Deaths: 0 deaths

Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg

Serious events: 0 serious events
Other events: 13 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Epidural Saline + IV Saline
n=14 participants at risk
Sterile saline via the epidural catheter. Sterile saline via intravenous catheter. Epidural saline + IV saline: Sterile saline injection in the epidural catheter and in the intravenous catheter
Epidural Morphine 3 mg + IV Saline
n=26 participants at risk
3 milligrams morphine via the epidural catheter. Sterile saline via intravenous catheter. Epidural morphine 3 mg + IV saline: Morphine 3 milligrams injection in the epidural catheter and sterile normal saline intravenous catheter
Epidural Morphine 3 mg + IV Ketamine 0.3 mg/kg
n=25 participants at risk
3 milligrams morphine via the epidural catheter. Ketamine 0.3 milligrams per kilogram via intravenous catheter. Epidural morphine 3 mg + IV ketamine 0.3 mg/kg: Morphine 3 milligrams injection in the epidural catheter and 0.3 milligrams per kilogram weight infused in the intravenous catheter
Gastrointestinal disorders
Vomiting
0.00%
0/14 • 48 Hours after delivery of baby.
3.8%
1/26 • Number of events 1 • 48 Hours after delivery of baby.
8.0%
2/25 • Number of events 2 • 48 Hours after delivery of baby.
General disorders
Hives
0.00%
0/14 • 48 Hours after delivery of baby.
3.8%
1/26 • Number of events 1 • 48 Hours after delivery of baby.
0.00%
0/25 • 48 Hours after delivery of baby.
General disorders
Wound Problems
7.1%
1/14 • Number of events 1 • 48 Hours after delivery of baby.
0.00%
0/26 • 48 Hours after delivery of baby.
0.00%
0/25 • 48 Hours after delivery of baby.
Cardiac disorders
Hypotension
14.3%
2/14 • Number of events 2 • 48 Hours after delivery of baby.
11.5%
3/26 • Number of events 3 • 48 Hours after delivery of baby.
8.0%
2/25 • Number of events 2 • 48 Hours after delivery of baby.
General disorders
Pruritus
0.00%
0/14 • 48 Hours after delivery of baby.
11.5%
3/26 • Number of events 3 • 48 Hours after delivery of baby.
8.0%
2/25 • Number of events 2 • 48 Hours after delivery of baby.
General disorders
Fever
0.00%
0/14 • 48 Hours after delivery of baby.
7.7%
2/26 • Number of events 2 • 48 Hours after delivery of baby.
4.0%
1/25 • Number of events 1 • 48 Hours after delivery of baby.
Musculoskeletal and connective tissue disorders
Back Ache
7.1%
1/14 • Number of events 1 • 48 Hours after delivery of baby.
23.1%
6/26 • Number of events 6 • 48 Hours after delivery of baby.
16.0%
4/25 • Number of events 4 • 48 Hours after delivery of baby.
Gastrointestinal disorders
Nausea
0.00%
0/14 • 48 Hours after delivery of baby.
7.7%
2/26 • Number of events 2 • 48 Hours after delivery of baby.
12.0%
3/25 • Number of events 3 • 48 Hours after delivery of baby.

Additional Information

Paul C. Fitzgerald, RN, BSN, MS

Northwestern University

Phone: 312-695-1064

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place